# Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

> clinical trial · VERIFIED · 2026-06-29

Status: RECRUITING · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: X-linked Severe Combined Immunodeficiency (XSCID)

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT01306019

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.